Figure 4.
Figure 4. Cumulative incidence of GvHD. (A) Cumulative incidence of grade II or higher acute GvHD according to the conditioning regimen (death not related to acute GvHD considered as a competing risk), 100-day cumulative incidence Cy-TAI, 41.8% (SE, 5%); Cy-ATG, 0%; Gray test, P < .0001. (B) Cumulative incidence of chronic GvHD according to conditioning: Cy-TAI, 64.0% (SE, 5.3%); Cy-ATG, 42.2% (SE, 9.6%); Gray test, P = .025.

Cumulative incidence of GvHD. (A) Cumulative incidence of grade II or higher acute GvHD according to the conditioning regimen (death not related to acute GvHD considered as a competing risk), 100-day cumulative incidence Cy-TAI, 41.8% (SE, 5%); Cy-ATG, 0%; Gray test, P < .0001. (B) Cumulative incidence of chronic GvHD according to conditioning: Cy-TAI, 64.0% (SE, 5.3%); Cy-ATG, 42.2% (SE, 9.6%); Gray test, P = .025.

Close Modal

or Create an Account

Close Modal
Close Modal